Archer Daniels Midland (ADM) plunges after placing CFO on leave amid probe

Stifel Downgrades Archer Daniels Midland (ADM) to Hold, 'we expect a sustained headwind to valuation on shares'

Stifel analyst Vincent Anderson downgraded Archer Daniels Midland (NYSE: ADM) from Buy to Hold with a price target of $56.00 (from $116.00).

The analyst comments "We are updating our model for market data observed throughout the quarter ahead of ADM's 4Q23 reporting. We also... More

Roth/MKM Downgrades Archer Daniels Midland (ADM) to Neutral

Roth/MKM analyst Brian Wright downgraded Archer Daniels Midland (NYSE: ADM) from Buy to Neutral with a price target of $66.00 (from $98.00).

The analyst comments "On Sunday evening, ADM announced that the CFO, Vikram Luther, was put on administrative leave as a result of an ongoing... More

Archer Daniels Midland (ADM) Appoints Ismael Roig as Interim CFO

ADM (NYSE: ADM) today announced the appointment of Ismael Roig as Interim Chief Financial Officer. Mr. Roig is a skilled executive deeply familiar with ADMs business, having served in a variety of global operational and financial leadership roles since joining the Company in 2004. The appointment follows the decision of the ADM Board of Directors to place Vikram Luthar, Chief Financial Officer and Senior Vice President, on administrative leave, effective immediately.

Mr. Luthars leave is pending an ongoing investigation being conducted by outside counsel for ADM and the Boards Audit Committee regarding certain... More

Goldman Sachs Downgrades Archer Daniels Midland (ADM) to Neutral

Goldman Sachs analyst Adam Samuelson downgraded Archer Daniels Midland (NYSE: ADM) from Buy to Neutral with a price target of $67.00 (from $90.00).

For an analyst ratings summary and ratings history on Archer Daniels Midland... More

Baird Downgrades Archer Daniels Midland (ADM) to Neutral, 'Pending Investigation and Risk to Estimates'

(Updated - January 22, 2024 4:24 AM EST)

Baird analyst Ben Kallo downgraded Archer Daniels Midland (NYSE: ADM) from Outperform to Neutral with a price target of $61.00 (from $96.00).

The analyst comments "We are downgrading shares based on the recently announced investigation into ADM's Nutrition segment... More